Integra LifeSciences | IART - Interest Expense On Debt


Integra LifeSciences reported $22.99M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Boston Scientific USD 96M 6M Jun/2026
CONMED USD 7.88M 823K Jun/2026
Cooper Companies USD 20.9M 1.5M Mar/2026
Dexcom USD 3.1M 1.1M Mar/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Globus Medical USD 5.49B 48.7M Jun/2026
HeartBeam USD 744K 2K Dec/2021
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.99M 529K Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 176M 5M Mar/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Orthofix International 4.68M 731K Sep/2025
Smith & Nephew USD 69M 1000K Dec/2025
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 1.15B Mar/2026
Teleflex USD 25.72M 2.43M Mar/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026